PL1863469T3 - Miejscowa kompozycja przeciwbólowa - Google Patents

Miejscowa kompozycja przeciwbólowa

Info

Publication number
PL1863469T3
PL1863469T3 PL06721260T PL06721260T PL1863469T3 PL 1863469 T3 PL1863469 T3 PL 1863469T3 PL 06721260 T PL06721260 T PL 06721260T PL 06721260 T PL06721260 T PL 06721260T PL 1863469 T3 PL1863469 T3 PL 1863469T3
Authority
PL
Poland
Prior art keywords
burn
abrasion
analgesic composition
analgesia
topical analgesic
Prior art date
Application number
PL06721260T
Other languages
English (en)
Inventor
Meredith Sheil
Allan Giffard
Charles Robert Olsson
Original Assignee
Animal Ethics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005901250A external-priority patent/AU2005901250A0/en
Application filed by Animal Ethics Pty Ltd filed Critical Animal Ethics Pty Ltd
Publication of PL1863469T3 publication Critical patent/PL1863469T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0076—Sprayable compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/442—Colorants, dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06721260T 2005-03-15 2006-03-15 Miejscowa kompozycja przeciwbólowa PL1863469T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
AU2005901250A AU2005901250A0 (en) 2005-03-15 A Topical Anaesthetic Composition
AU2005902296A AU2005902296A0 (en) 2005-05-06 A Topical Anaesthetic Composition
AU2005905062A AU2005905062A0 (en) 2005-09-14 A Topical Anaesthetic Composition
AU2005906965A AU2005906965A0 (en) 2005-12-12 A Topical Anaesthetic Composition
EP06721260A EP1863469B1 (en) 2005-03-15 2006-03-15 A topical analgesic composition
PCT/AU2006/000337 WO2006096914A1 (en) 2005-03-15 2006-03-15 A topical analgesic composition

Publications (1)

Publication Number Publication Date
PL1863469T3 true PL1863469T3 (pl) 2012-05-31

Family

ID=36991190

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06721260T PL1863469T3 (pl) 2005-03-15 2006-03-15 Miejscowa kompozycja przeciwbólowa

Country Status (11)

Country Link
US (3) US8822416B2 (pl)
EP (2) EP1863468B1 (pl)
AT (1) ATE537820T1 (pl)
AU (4) AU2006202528B2 (pl)
CA (2) CA2656966C (pl)
DK (2) DK1863469T3 (pl)
ES (2) ES2585654T3 (pl)
NZ (2) NZ591035A (pl)
PL (1) PL1863469T3 (pl)
PT (1) PT1863469E (pl)
WO (2) WO2006096914A1 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR058254A1 (es) * 2005-11-29 2008-01-30 Australian Wool Innovation Ltd Un metodo para administrar una composicion a un animal
AU2006287247C1 (en) * 2005-11-29 2008-08-21 Australian Wool Innovation Limited Method for administering a composition to an animal
US8541022B2 (en) * 2008-06-02 2013-09-24 Galderma S.A. Method of treating burns using avermectin compound
ITMI20081478A1 (it) * 2008-08-06 2010-02-07 Moldes S R L Formulazione di gel acquoso per la somministrazione di sostanze farmaceutiche e/o nutritive
US20110077512A1 (en) * 2009-06-16 2011-03-31 Dept. Of Veterans Affairs Biopsy marker composition and method of use
RU2554795C2 (ru) * 2009-09-21 2015-06-27 Мериал Лимитед Водная суспензия длительного хранения на основе дицикланила и составы из неводной суспензии для применения путем промывания и опрыскивания, пригодные для профилактики и лечения заражения насекомыми у животных
TR201009220A1 (tr) * 2010-11-08 2012-05-21 Sanovel �La� San. Ve T�C. A.�. Flurbiprofen ve metil salisilat topikal farmasötik bileşimleri.
US20140348774A1 (en) * 2010-12-10 2014-11-27 Aurora Pharmaceutical, LLC Method for treating wounds and tissue repair
EP2654757A1 (en) * 2010-12-22 2013-10-30 Entarco SA The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents
FR2977493B1 (fr) * 2011-07-05 2014-02-14 Galderma Res & Dev Nouvelle composition anesthesique stable pour la reduction des reactions cutanees
FR2980363B1 (fr) * 2011-09-22 2014-11-28 Arcadophta Composition a toxicite reduite d'au moins un colorant stable et pouvant etre sterilisee
EP2620144A1 (en) * 2012-01-27 2013-07-31 Medical Technology Transfer Holding B.V. Staining Composition
US9173941B1 (en) 2012-08-02 2015-11-03 Jeff Shear Sustained release bittering composition
SG10202001661TA (en) * 2015-08-27 2020-04-29 Alkalidx Inc Devices, kits, and methods for determining ineffectiveness of anesthetics
US10039830B2 (en) 2016-03-04 2018-08-07 Cetylite Industries, Inc. Topical anesthetic composition
MX389336B (es) 2016-11-15 2025-03-20 Klaria Pharma Holding Ab Formulacion farmaceutica.
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
WO2019005700A1 (en) * 2017-06-26 2019-01-03 Merial, Inc. DOUBLE-ACTING PARASITICIDE GRANULATE COMPOSITIONS, METHODS AND USES THEREOF
DE102017121900A1 (de) 2017-09-21 2019-03-21 Ferhan Toprak Kombination von Tätowiertinte und einem oder mehreren Lokalanästhetika
CA3085466A1 (en) * 2017-12-11 2019-06-20 Animal Ethics Pty Ltd Wound dressing
AU2019101824A4 (en) * 2018-03-09 2022-02-17 Animal Ethics Pty Ltd Cooling composition and method of use
GB201808462D0 (en) * 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
EP3902522B1 (en) 2018-12-27 2023-10-04 Pacheco dos Santos Dias, José António Gel composition with an anaesthetic effect of short and long term duration
WO2020210889A1 (pt) * 2019-04-18 2020-10-22 Hexsel, Doris Maria Composição de tinta para marcação de tecido orgânico com anestésico e método de aplicação da mesma
RU2714074C1 (ru) * 2019-04-23 2020-02-11 Андрей Владимирович Резвов Бинт перевязочный перфорированный (варианты)
US20220211620A1 (en) * 2019-05-28 2022-07-07 Animal Ethics Pty Ltd Pain Relieving Spray
CA3141886A1 (en) * 2019-05-28 2020-12-03 Animal Ethics Pty Ltd Method of disease control
US12409155B1 (en) * 2021-03-18 2025-09-09 QuVa Pharma Inc. Ready to use LET formulations
US20240226034A1 (en) * 2021-04-29 2024-07-11 The Regents Of The University Of California Use of Terpenoids and Salicylates as Anesthetics and Analgesics
AU2021203856B2 (en) * 2021-06-10 2023-03-09 Animal Ethics Pty Ltd Topical anaesthetic composition having improved vasoconstrictor stability
US12514756B1 (en) 2024-10-08 2026-01-06 Covidien Lp Dermal patch and systems, kits, and methods associated therewith

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3832460A (en) 1971-03-19 1974-08-27 C Kosti Anesthetic-vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue
US4248855A (en) 1976-08-27 1981-02-03 Hydrophilics International, Inc. Pharmaceutical base salts
AU524658B2 (en) 1978-05-22 1982-09-30 Ici Australia Limited Depilatory composition for sheep
EP0040862A1 (en) * 1979-01-11 1981-12-02 Key Pharmaceuticals, Inc. Burn matrix, method of its preparation and delivery device comprising said matrix
CH668912A5 (fr) 1986-12-12 1989-02-15 Paul Dr Med Herzog Composition desinfectante a usage humain ou veterinaire.
AU647784B2 (en) 1990-03-27 1994-03-31 Commonwealth Scientific And Industrial Research Organisation Non surgical mulesing
US5098417A (en) * 1990-04-12 1992-03-24 Ricoh Kyosan, Inc. Cellulosic wound dressing with an active agent ionically absorbed thereon
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
US5804213A (en) * 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
AU3941493A (en) 1992-03-30 1993-11-08 Alza Corporation Viscous suspensions of controlled-release drug particles
JPH07157427A (ja) 1993-12-02 1995-06-20 Fujisawa Pharmaceut Co Ltd 歯科用表面麻酔剤
GB9408545D0 (en) 1994-04-29 1994-06-22 Zyma Sa Compositions
US5585398A (en) 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
ATE223202T1 (de) 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung
US5583153A (en) * 1994-10-06 1996-12-10 Regents Of The University Of California Use of taxol in the treatment of rheumatoid arthritis
US5563153A (en) 1995-02-22 1996-10-08 University Of Kansas Medical Center Sterile topical anesthetic gel
NZ311474A (en) 1995-06-09 1997-09-22 Euro Celtique Sa Formulations for providing prolonged local anesthesia
JP3628809B2 (ja) 1996-06-10 2005-03-16 アルケア株式会社 薬剤徐放性医療用配合物及びその製造方法
SE9602829D0 (sv) * 1996-07-19 1996-07-19 Yngve Johnsson Förfarande och anordning för betalningsmedelshantering jämte betalningsmedel
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
AU2590697A (en) * 1997-03-07 1998-09-22 Richard R. Jackson Anesthetizing plastics, drug delivery plastics, and related medical products, s ystems and methods
IL135258A0 (en) * 1997-09-26 2001-05-20 Noven Pharma Bioadhesive compositions and methods for topical administration of active agents
US6295469B1 (en) * 1997-11-14 2001-09-25 Alza Corporation Formulation for electrically assisted delivery of lidocaine and epinephrine
US5993836A (en) 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
AU1824300A (en) 1998-11-23 2000-06-13 Linden Biotechnology, Inc. Combination products of a guanylate cyclase inhibitor and a local anesthetic forpain relief
US6075059A (en) 1999-02-24 2000-06-13 The Ohio State University Compositions for dental anesthesia
AUPQ044499A0 (en) 1999-05-19 1999-06-10 Commonwealth Scientific And Industrial Research Organisation Control of wool growth
US6375963B1 (en) * 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
US6383511B1 (en) 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
AUPQ419099A0 (en) 1999-11-23 1999-12-16 Ko, Thomas Sai Ying Novel compositions and methods
EP1176933A1 (en) 2000-01-14 2002-02-06 Zila, Inc. Topical medicated bioadhesive compositions and methods of use and preparation thereof
WO2001054679A2 (en) 2000-01-27 2001-08-02 Children's Hospital Research Foundation Transdermal composition containing an anesthetic and a vasodilator agent
US6558653B2 (en) 2001-09-19 2003-05-06 Scot N. Andersen Methods for treating periodontal disease
US6620852B2 (en) 2001-12-17 2003-09-16 Gerald Brogan Topical anesthetic
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
US6855341B2 (en) * 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions
US7687080B2 (en) * 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
WO2004058329A2 (en) 2002-12-20 2004-07-15 The Board Of Trustees Of The Leland Stanford Junior University Ester combination local anesthetic
WO2005032521A2 (en) 2003-10-02 2005-04-14 Collegium Pharmaceutical, Inc. Non-flammable topical anesthetic liquid aerosols
DE102004001093A1 (de) 2004-01-05 2005-07-28 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer synergistischen topischen Therapie neuromuskulärer Schmerzen
GB2414184A (en) * 2004-02-20 2005-11-23 Himedica Ltd Liquid bandage composition

Also Published As

Publication number Publication date
EP1863468A4 (en) 2010-11-17
AU2008201484A1 (en) 2008-04-24
US20080131527A1 (en) 2008-06-05
DK1863468T3 (en) 2016-08-15
AU2010100049A6 (en) 2012-06-28
CA2656966C (en) 2014-06-10
EP1863469A1 (en) 2007-12-12
NZ591035A (en) 2012-09-28
WO2006096913A1 (en) 2006-09-21
EP1863468B1 (en) 2016-05-11
US8822416B2 (en) 2014-09-02
US8960128B2 (en) 2015-02-24
EP1863469A4 (en) 2009-06-03
AU2006202528A1 (en) 2006-10-05
ES2379190T3 (es) 2012-04-23
EP1863469B1 (en) 2011-12-21
AU2010100050A4 (en) 2010-02-18
CA2656961C (en) 2014-07-22
CA2656966A1 (en) 2006-09-21
US20140335206A1 (en) 2014-11-13
US9592318B2 (en) 2017-03-14
AU2006202528B2 (en) 2008-01-03
DK1863469T3 (da) 2012-03-26
ATE537820T1 (de) 2012-01-15
AU2010100050A6 (en) 2012-06-28
NZ552862A (en) 2009-03-31
AU2010100049A4 (en) 2010-02-18
US20080085245A1 (en) 2008-04-10
ES2585654T3 (es) 2016-10-07
PT1863469E (pt) 2012-03-22
CA2656961A1 (en) 2006-09-21
EP1863468A1 (en) 2007-12-12
WO2006096914A1 (en) 2006-09-21

Similar Documents

Publication Publication Date Title
PL1863469T3 (pl) Miejscowa kompozycja przeciwbólowa
MX2024012963A (es) Compuestos de modulacion de kras g12d
BR0314743A (pt) Envoltórios perivasculares
CY1112387T1 (el) Θεραπευτικη συνθεση περιεχουσα τουλαχιστον ενα παραγωγο της πυρρολοβενζοδιαζεπινης και φλουδαραβινη
ECSP099472A (es) Combinación de inhibidores de iap e inhibidores de flt3
AU2007247480A8 (en) Pharmaceutical combination comprising 3- (3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and an NSAID
WO2005117870A3 (en) Combination of proton pump inhibitor, buffering agent, and prokinetic agent
WO2006034249A3 (en) Antimicrobial amorphous compositions
PT1286671E (pt) Composicoes para o tratamento de cancro colorrectalque compreendem talidomida e irinotecan
CL2008001171A1 (es) Composicion farmaceutica que comprende fibrinogeno, trombina y un compuesto que contiene estroncio; y su uso en el tratamiento de un hueso enfermo, dañado, deficiente o defectuoso.
WO2007146983A3 (en) Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury
CL2011000798A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
NO341602B1 (no) Farmasøytisk kombinasjon omfattende 3-(3-dimetylamino-1-etyl-2-metyl-propyl)-fenol og paracetamol
WO2008042480A3 (en) Epoxide inhibitors of cysteine proteases
GEP20115230B (en) Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome p450 3a4
CL2011002233A1 (es) Metodo para tratar o prevenir el cancer, que comprende administrar una combinacion farmaceutica sinergica de: a) (s)-n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)-6-metoxifenil)-1-(2,3-dihidroxipropil)ciclopropan-1-sulfonamida y b) 3-(6,7-bis(2-metoxietoxi)quinazolin-4-ilamino)benzonitrilo; composicion farmaceutica; y kit farmaceutico.
IL178591A (en) 4– (Amino) –2– (2,6 – Dioxo (3-piperidyl)) - Isoindulin – 1,3 – Dion for the treatment and management of myelodysplastic syndromes
WO2007044396A3 (en) Fibronectin polypeptides and methods of use
WO2007061942A3 (en) Compositions for disrupting and inhibiting reconstitution of wound biofilm
EA200970353A1 (ru) Комбинированное лекарственное средство
CL2011000805A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion de lictus en pacientes que padecen fibrilacion auricular.
BRPI0508596A (pt) combinação compreendendo ligante alfa-2-delta
WO2006126188A3 (en) Cxcr4 antagonists for wound healing and re-epithelialization
WO2004071385A3 (en) Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention
WO2008138089A3 (en) Pharmaceutical composition comprising a local anaesthetic and a carboxyvinyl polymer